pharma · Chronic Hepatitis D Infection · Chronic Hepatitis Delta Infection
Blue Earth Diagnostics
Blue Earth Diagnostics Ireland Ltd
Blue Earth Diagnostics is a pharma organization headquartered in GB. Primary therapeutic focus areas include Chronic Hepatitis D Infection, Chronic Hepatitis Delta Infection, PSMA-positive non-curative metastatic castrat
Company details
- Status
- Public
- HQ
- Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB
- Founded
- 2014
- Employees
- 120
- Programs
- 11
- Drugs
- 12
- Patents
- 0
[68Ga]BED003 injection
Phase 2 · small molecule · Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
[68Ga]BED003 injection for Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC). is a Phase 2 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).
Internal code BED-FAP-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Blue Earth Diagnostics Ireland Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
- Status
- active
- Trials
- 1